Synthon receives European approvals for Rosuvastatin
Synthon announced today that it has successfully concluded multiple registration procedures for Rosuvastatin 5mg, 10mg, 15mg, 20mg and 40mg film-coated immediate release tablets. Regulatory clearance for Rosuvastatin has been obtained in 14 European countries.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.